China scores first international regulatory approval with encephalitis vax; Amarin's Vascepa to meet FDA advisory committee;

@FiercePharma: Tops this AM on our website: Novartis eyes sell-offs, with decision on individual units expected soon. More | Follow @FiercePharma

@EricPFierce: Ranbaxy shopping for FDA approved plant. Article | Get all FiercePharmaManufacturing headlines via email | Follow @EricPFierce

@CarlyHFierce: GSK has always said it would be difficult to copy its respiratory drug Advair--and Teva agrees. Article | Follow @CarlyHFierce

> Chengdu Institute of Biological Products became the first Chinese company to have one of its drugs or vaccines approved internationally; its vaccine to protect against Japanese encephalitis received pre-qualification from the World Health Organization (WHO). Story (sub. req.)

> The Scottish Medicines Consortium has approved Lundbeck's Selincro for use by the country's National Health Services as a treatment for alcohol dependence. Article

> In trials, a high dose of Pfizer's ($PFE) tofacitinib proved as effective as Amgen's ($AMGN) Enbrel in treating adults with moderate-to-severe psoriasis. Report

> Amarin's ($AMRN) fish oil pill Vascepa is up for an FDA advisory committee meeting Oct. 16 that will determine whether it becomes the only prescription omega-3 therapy approved for patients with moderately high triglycerides and mixed dyslipidemia. Story

> The FDA is investigating a growing list of reports of non-viral hepatitis in Hawaii that have already led to 11 hospitalizations and one death. Dietary supplement OxyElite Pro appears to be a common link between at least 24 of 29 cases. Report

> Dutch biotech Pharming is placing €12 million ($16.3 million) of new shares to fund the manufacturing of a hereditary angioedema treatment and a clinical trial. Item

Medical Device News

@FierceMedDev: ICYMI: Med tech's hottest takeover targets for the rest of 2013. Special report | Follow @FierceMedDev

> Boston Scientific touts positive data for PAD catheter. More

> Medtronic jumps into hemodialysis business through India partnership. Story

> Medtronic wins FDA panel support to expand pacemaker and defibrillator use. Item

Biotech News

@FierceBiotech: Popular from FierceCRO - Analyst: Bet on another boom for big CROs. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: 10 top drugs in biopharma's late-stage pipeline. Special report | Follow @JohnCFierce

@DamianFierce: Time to find out whether device firms are allowed at the biotech IPO party: LDR prices a $75M debut. News | Follow @DamianFierce

@EmilyMFierce: Altered antimicrobials could combat drug-resistant bacteria. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> Ariad hammered on toxicity concerns for leukemia drug Iclusig. News

> Bayer wins key FDA approval for lung disease drug Adempas. More

> Shutdown nixes Merck's FDA panel date, spares other drugs. Story

Drug Delivery News

@MichaelGFierce: Stem cell 'drug factories' target, treat inflammation. More | Follow @MichaelGFierce

> U.S.-based scientists win Nobel Prize for cell transport exploration. Item

> Study: Disc-shaped nanoparticles best at crossing cell membranes. More

> Cook touts positive data for Zilver paclitaxel-eluting stent after April recall. Story

> Alnylam posts positive PhI for RNAi cholesterol drug. Report

Diagnostics News

@MarkHFierce: Sign up for your free, weekly dose of FierceDiagnostics. Sign up here | Follow @MarkHFierce

> Roche looks to the future with two new molecular Dx systems. Article

> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Story

> Boreal Genomics pulls in $18M Series C for genomic research and Dx test expansion. Report

> Renishaw Diagnostics seals deal with tech transfer group to develop infectious disease tests. More

And Finally... Three U.S.-based scientists picked up the Nobel Prize in chemistry for developing powerful computer models that researchers can use to explore complex chemical interactions and create new drugs. Story